Barbara Malvestiti
YOU?
Author Swipe
View article: VP29.09: Abstract withdrawn
VP29.09: Abstract withdrawn Open
Virtual poster abstractsCVS and 10 (1.3%) had an amniocentesis even after a normal 1T/2T screen.Of the 273 mothers who had ''high risk'' on the cFT screen with a normal fetal scan, 117 (42.8%) had amniocentesis, 91 (33.3%) had cfDNA and 65…
View article: VP29.10: Abstract withdrawn
VP29.10: Abstract withdrawn Open
Virtual poster abstractsCVS and 10 (1.3%) had an amniocentesis even after a normal 1T/2T screen.Of the 273 mothers who had ''high risk'' on the cFT screen with a normal fetal scan, 117 (42.8%) had amniocentesis, 91 (33.3%) had cfDNA and 65…
View article: OC11.10: Diagnostic cytogenetics and cytogenomics confirmations following a cfDNA test with a high‐risk or inconclusive result
OC11.10: Diagnostic cytogenetics and cytogenomics confirmations following a cfDNA test with a high‐risk or inconclusive result Open
Retrospective analysis of diagnostic results on samples submitted to a single medical genetics laboratory for confirmatory studies after a high-risk or inconclusive cfDNA test. Samples include POCs, CVS, AF and newborn blood received from …
View article: Supplementary Material for: First Trimester Screening for Common Trisomies and Microdeletion 22q11.2 Syndrome Using Cell-Free DNA: A Prospective Clinical Study
Supplementary Material for: First Trimester Screening for Common Trisomies and Microdeletion 22q11.2 Syndrome Using Cell-Free DNA: A Prospective Clinical Study Open
Objectives: The aims of the study were to assess the false-positive and uninformative test rate with first trimester cell-free DNA (cfDNA) screening for common trisomies and microdeletion 22q11.2 (22q11.2DS) and to examine wo…
View article: First Trimester Screening for Common Trisomies and Microdeletion 22q11.2 Syndrome Using Cell-Free DNA: A Prospective Clinical Study
First Trimester Screening for Common Trisomies and Microdeletion 22q11.2 Syndrome Using Cell-Free DNA: A Prospective Clinical Study Open
Objectives: The aims of the study were to assess the false-positive and uninformative test rate with first trimester cell-free DNA (cfDNA) screening for common trisomies and microdeletion 22q11.2 (22q11.2DS) and to examine women’s attitude…